30 Participants NeededMy employer runs this trial

Brain Stimulation for Dementia

(BWIBS-WM Trial)

AN
AH
Overseen ByAmeer Hamoodi
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: McMaster University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve working memory in people with dementia using a method called EEG-triggered transcranial magnetic stimulation (TMS). TMS safely and non-invasively sends brief electrical currents to the brain, helping brain waves realign. The goal is to ease daily tasks like conversations and remembering lists for dementia patients, potentially reducing the burden on their families. Individuals diagnosed with Alzheimer's Disease or related dementias who can understand English instructions might be suitable candidates for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance daily life for dementia patients.

What prior data suggests that this brain stimulation technique is safe for dementia patients?

Research has shown that transcranial magnetic stimulation (TMS) is generally well-tolerated by individuals with mild memory problems. Studies have found that TMS can be safely combined with EEG, a test that measures brain waves, to study brain activity and potentially enhance thinking skills.

For instance, one study found that TMS, when used with EEG, had manageable side effects in people with mild memory issues. Another review found that repetitive TMS (rTMS), a similar treatment, provided moderate improvements in thinking skills and was particularly effective at higher frequencies.

The FDA has approved TMS for treating certain mental health conditions, indicating its safety for humans. While ongoing research continues, current evidence supports the safety of TMS, making it a promising option for potentially improving memory in individuals with dementia.12345

Why are researchers excited about this trial?

Researchers are excited about EEG-triggered Transcranial Magnetic Stimulation (TMS) because it offers a new way to potentially enhance working memory in dementia patients. Unlike standard treatments like medications that aim to manage symptoms, EEG-triggered TMS uses real-time brain wave monitoring to precisely deliver magnetic stimulation to specific brain areas involved in memory. This approach could lead to more targeted and effective interventions by synchronizing the treatment with the brain's natural rhythms. This innovative method holds promise for improving cognitive function in ways traditional treatments cannot.

What evidence suggests that EEG-triggered TMS is effective for improving working memory in dementia?

This trial will investigate EEG-triggered transcranial magnetic stimulation (TMS) for dementia. Studies have shown that combining TMS with EEG, a test measuring brain activity, may enhance thinking skills in people with dementia. Research suggests that TMS can improve the coordination of brain waves, which is crucial for memory. In individuals with Alzheimer's disease, TMS has been linked to enhanced overall cognitive abilities. Specifically, TMS can improve memory by aligning brain waves, aiding tasks like remembering lists or following directions. Overall, strong evidence indicates that EEG-guided TMS can positively impact thinking skills in dementia.12356

Are You a Good Fit for This Trial?

This trial is for people diagnosed with dementia, including Alzheimer's disease. Participants should be adults who are able to take part in brain stimulation and EEG procedures.

Inclusion Criteria

Participants must demonstrate an understanding of instruction provided in English
I have been diagnosed with Alzheimer's or a related dementia by a doctor.
I am at least 55 years old.
See 1 more

Exclusion Criteria

Allergy to rubbing alcohol needed to prepare electromyography for TMS
I do not have implants, seizure risk, uncontrolled mental illness, or pregnancy.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive EEG-triggered TMS intervention aimed at improving working memory by synchronizing brain waves

2 weeks
Multiple sessions (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments of cognitive function

4 months
Assessments at 1 month and 4 months post-treatment

What Are the Treatments Tested in This Trial?

Interventions

  • EEG-triggered Transcranial Magnetic Stimulation (TMS)

Trial Overview

The study tests a non-invasive treatment called transcranial magnetic stimulation (TMS), which is timed using each person's brain waves measured by EEG, to see if it can improve working memory in people with dementia.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Intervention: EEG-triggered TMSExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials
936
Recruited
2,630,000+

Citations

Exploring the potential of combining transcranial magnetic ...

Moreover, the TMS-induced EEG features were observed to be correlated with cognitive performance and the presence of AD pathological biomarkers. The ...

Brain Stimulation Can Help Measure Alzheimer's Disease ...

EEG captures how activity spreads across the scalp after stimulation, and PCI–ST quantifies the number of state transitions in these TMS-evoked ...

Breakdown of TMS evoked EEG signal propagation within ...

TMS-EEG in AD shows both local hyperexcitability and a lack of signal propagation within the DMN. These neurophysiological features also correlate with ...

Transcranial Magnetic Stimulation in Mild Cognitive ...

Neurocognitive outcomes were compared between magnetic resonance imaging (MRI) and electroencephalogram (EEG)-grid guided TMS in patients. Tolerability data was ...

TMS-EEG Biomarkers of Amnestic Mild Cognitive ...

Results: Patients with aMCI showed reduced motor cortex (M1) excitability and disrupted EEG synchronization [decreased intertrial coherence (ITC)] ...

TMS–EEG Co-Registration in Patients with Mild Cognitive ...

The TMS–EEG response P30 amplitude correlated with cognitive impairment and exhibited good specificity and sensitivity in identifying control ...